Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development
about
Comparing in vitro and in vivo virulence phenotypes of Burkholderia pseudomallei type G strains.Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in MiceBurkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Innate immune response to Burkholderia mallei.The Use of Reverse Vaccinology in the Design and Construction of Nano-glycoconjugate Vaccines against Burkholderia pseudomallei.Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.Iron Acquisition Mechanisms and Their Role in the Virulence of Burkholderia Species.Characterization of the Burkholderia cenocepacia TonB Mutant as a Potential Live Attenuated Vaccine.Melioidosis: where do we stand in the development of an effective vaccine?Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice.Vaccines for the Prevention of Melioidosis and Glanders.
P2860
Q33570950-693809BC-1527-49AC-9D65-BDA0A628E287Q36277130-60A963F3-DE45-47CF-8494-0C6D11BBD9A6Q36620684-FD362974-7088-4C5D-8765-2B0961D21B5DQ37129909-326C1979-67B8-4BE9-AE4A-A205B6489B1EQ38784773-B2C89053-464D-44F0-BD2F-C27E4F168D6CQ38890754-08D71D14-9862-473B-BE39-6DA05D890EB0Q39126286-7ABF0EE4-E776-401F-B03A-8C1A6EC080ABQ40048191-0B34C2CD-7025-4090-990D-68E92BEB99C8Q40286028-B7B920A8-8FC3-4681-884F-21F0B2529505Q45722019-422009B5-5819-4CA3-8C35-9CA9B3A25EEAQ47168921-3A9EC298-7C52-43BC-B185-E48A2675BBDBQ48144660-A52628DF-8349-440F-A68A-000D93C9920DQ48270562-9529D54B-E797-43C5-A3A0-54ADFA613BDFQ49834322-83932810-0862-47BD-B39E-1DF5D29CEBAB
P2860
Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Characterization of the Burkho ...... Strain for Vaccine Development
@ast
Characterization of the Burkho ...... Strain for Vaccine Development
@en
Characterization of the Burkho ...... Strain for Vaccine Development
@nl
type
label
Characterization of the Burkho ...... Strain for Vaccine Development
@ast
Characterization of the Burkho ...... Strain for Vaccine Development
@en
Characterization of the Burkho ...... Strain for Vaccine Development
@nl
prefLabel
Characterization of the Burkho ...... Strain for Vaccine Development
@ast
Characterization of the Burkho ...... Strain for Vaccine Development
@en
Characterization of the Burkho ...... Strain for Vaccine Development
@nl
P2093
P2860
P1476
Characterization of the Burkho ...... Strain for Vaccine Development
@en
P2093
Elena Sbrana
Janice J Endsley
Sudhamathi Vijayakumar
Tiffany M Mott
P2860
P304
P356
10.1371/JOURNAL.PNTD.0003863
P407
P577
2015-06-26T00:00:00Z